Search

everythinglearnresearchcommunity

for

Search:↓

TIP39 and PTH2R help control calcium levels and skin cell development.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

Medications for PCOS don't seem to raise heart disease risk.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Hair glycation can indicate long-term blood sugar levels and diabetic nerve issues.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Dopaminergic neurons in the gut have distinct subtypes, some releasing both dopamine and acetylcholine.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Higher levels of the DP2 receptor may lead to hair loss.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.